Literatur
-
1
Adler A I, Stratton I M, Neil H A. et al .
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
Brit Med J.
2000;
321
412-419
-
2
Gaede P, Vedel P, Larsen N, Jensen G V, Parving H H, Pedersen O.
Multifactorial intervention and cardiovascular diesase in patients with type 2 diabetes.
N Engl J Med.
2003;
348
383-393
-
3
Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez L A, Hallas J, Sindrup S H.
Statins and risk of polyneuropathy. A case-control study.
Neurology.
2002;
58
1333-1337
-
4
Jones J K, Gorkin L, Lian J F, Staffa J A, Fletcher A P.
Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population.
Br Med J.
1995;
311
293-295
-
5
Liebl A, Spannheimer A, Reitberger U, Wagenpfeil S, Görtz A.
Aktuelles Diabetes-Management für Patienten mit Typ 2-Diabetes in Deutschland. Ergebnisse der CODE-2-Studie.
Diab Stoffw.
2002;
11
55-61
-
6
Nielsen I, Icks A, Rathmann W, Haastert B, Giani G.
Discontinuation of treatment after start of new course of antihypertensive drugs in diabetic patients with newly diagnosed hypertension.
Pharmacoepidemiol Drug Safety.
2002;
11
S146
(Suppl 1)
-
7
Rathmann W, Haastert B, Roseman J M, Gries F A, Giani G.
Prescription drug use and costs among diabetic patients in primary health care practices in Germany.
Diabetes Care.
1998;
21
389-397
-
8
Rathmann W, Haastert B, Roseman J M, Giani G.
Cardiovascular drug prescriptions and risk of depression in diabetic patients.
J Clin Epidemiol.
1999;
52
1103-1109
-
9
Rathmann W.
Costs and effectiveness of medications in diabetic patients.
Drug Benefit Trends.
1998; 10;
24-33
-
10
Rathmann W, Haastert B, Icks A. et al .
High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA Survey 2000.
Diabetologia.
2003;
46
182-189
-
11
Rothenbacher D, Rüter G, Saam S, Brenner H.
Versorgung von Patienten mit Typ 2-Diabetes. Ergebnisse aus 12 Hausarztpraxen.
Dtsch Med Wochenschr.
2002;
127
1183-1187
-
12
Stratton I M, Adler A I, Neil H A. et al .
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
Brit Med J.
2000;
321
405-412
-
13
Thefeld W.
Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands.
Gesundheitswesen.
1999;
61
S85-S89
(Sonderheft 2))
-
14
Turner R C, Cull C A, Frighi V, Holman R R.. UK Prospective Diabetes Study (UKPDS) Group .
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49).
JAMA.
1999;
281
2005-2012
-
15
UK Prospective Diabetes Study (UKPDS) Group .
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
Lancet.
1998;
352
837-853
-
16
UK Prospective Diabetes Study (UKPDS) Group .
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.
Brit Med J.
1998;
317
703-713
-
17
UK Prospective Diabetes Study (UKPDS) Group .
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39.
Brit Med J.
1998;
317
713-720
-
18
Vijan S, Hayward R A.
Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
Ann Intern Med.
2003;
138
593-602
-
19
Wenzel U, Röben T, Schwietzer G, Stahl R AK.
Die Therapie der arteriellen Hypertonie. Eine Umfrage bei niedergelassenen Ärzten.
Dtsch Med Wochenschr.
2001;
126
1454-1459
Dr. Wolfgang Rathmann
Deutsches Diabetes-Forschungsinstitut
AufŽm Hennekamp 65
40225 Düsseldorf
Phone: 0211/3382663
Fax: 0211/3382677
Email: rathmann@ddfi.uni-duesseldorf.de
